FDA Class II · Drug · July 22, 2026
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0 recall — Chiesi USA, Inc.
Lack of Assurance of Sterility
Official ID D-0689-2026 · Official record ↗
Chiesi USA recalls
Recall found. Chiesi USA is named in FDA Class II recall D-0689-2026 covering CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0. Hazard: Lack of Assurance of Sterility Identifying details: Lot #: 1239521, 1237454, Exp. Date 10/2027. Status: Ongoing.
Models with recalls
All Chiesi USA recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked September 7, 2026 at 6:00 AM UTC.